clinical trial · NCT07746479
A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )
PsoriasisLZM012
brief summary
This study is a Multicenter, Open-Label, Single-Arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of LZM012 Injection in Patients With Moderate to Severe Plaque Psoriasis.
started
Jun 23, 2025
primary completion
Jan 26, 2026
completion
Jan 26, 2026
last updated
Aug 5, 2026
official title
A Multicenter, Open-Label, Single-Arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of LZM012 Injection in Patients With Moderate to Severe Plaque Psoriasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol